Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 2/20 | 0.38 |
| ▸ | TACR2 | P21452 | 1/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GLP1R | P43220 | 1/20 | 0.37 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7042531 | 0.96 | PARP1 (0.56) | PARP1KMT2AMEN1DRD4DRD3 | |
| SCHEMBL7040495 | 0.89 | PARP1 (0.65) | PARP1DRD3 | |
| SCHEMBL5620206 | 0.86 | PARP1 (0.70) | PARP1KMT2ADRD4DRD3 | |
| SCHEMBL7041082 | 0.86 | PARP1 (0.52) | PARP1KMT2AMEN1DRD4 | |
| SCHEMBL7044886 | 0.84 | THRB (0.41) | PARP1KMT2AMEN1DRD4 | |
| SCHEMBL7043510 | 0.83 | PARP1 (0.55) | PARP1KMT2AMEN1DRD4 | |
| SCHEMBL7040671 | 0.82 | PARP1 (0.50) | PARP1HRH1 | |
| SCHEMBL5621035 | 0.82 | PARP1 (0.76) | PARP1KMT2AMEN1DRD4DRD3 | |
| SCHEMBL6869195 | 0.81 | PARP1 (0.63) | PARP1 | |
| SCHEMBL7043751 | 0.81 | DRD2 (0.39) | PARP1KMT2AMEN1DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133477-B1 | SUBSTITUTED BENZIMIDAZOLES AND THEIR USE AS PARP INHIBITORS | ABBOTT GMBH & CO KG (DE) | 2004-02-18 | — | — | EP | disclosed |